A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2011.03.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Phase-Ii Study of Dose Attenuated Schedule of Irinotecan, Capecitabine, and Celecoxib in Advanced Colorectal Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2007English

"Poker" Association of Weekly Alternating 5-Fluorouracil, Irinotecan, Bevacizumab and Oxaliplatin (FIr-B/FOx) in First Line Treatment of Metastatic Colorectal Cancer: A Phase II Study

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

A Phase II Trial of Fixed-Dose Rate Gemcitabine Plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

Oncology
MedicineCancer ResearchOncology
2012English

Phase I Dose-Finding Study of Eribulin and Capecitabine for Metastatic Breast Cancer: JBCRG-18 Cape Study

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2017English

Reply: Capecitabine and Bevacizumab as First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2010English

Capecitabine in Combination With Oxaliplatin and Bevacizumab (AXELOX) as 1st Line Treatment for Fit and Vulnerable Elderly Patients (Aged >70 Years) With Metastatic Colorectal Cancer (mCRC): A Multicenter Phase II Study of the Hellenic Oncology Research Group (HORG)

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

A Phase 1 Study of Irinotecan, Capecitabine (Xeloda®), and Oxaliplatin (IXO) in Patients With Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2018English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Bevacizumab Combined With Gemcitabine and Capecitabine for Advanced Pancreatic Cancer: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy